Penumbra
PEN
#1666
Rank
$12.63 B
Marketcap
$320.60
Share price
0.47%
Change (1 day)
15.28%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

P/S ratio for Penumbra (PEN)

P/S ratio as of November 2026 (TTM): 8.10

According to Penumbra's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.25. At the end of 2026 the company had a P/S ratio of 8.02.

P/S ratio history for Penumbra from 2015 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20268.02-7.14%
20258.6312.03%
20247.71-15.99%
20239.17-8.04%
20229.97-30.54%
202114.426.63%
202011.37.95%
201910.511.05%
20189.46-1.15%
20179.5724.8%
20167.67-11.31%
20158.65

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Merit Medical
MMSI
3.20-60.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Inari Medical
NARI
8.15 0.66%๐Ÿ‡บ๐Ÿ‡ธ USA